DWA
PLSE icon

Dorsey Wright & Associates’s Pulse Biosciences PLSE Stock Holding History

Dorsey Wright & Associates’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-767
Closed -$18K – 354
2020
Q4 		$18K Buy
+767
New +$12.2K ﹤0.01% 189

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TCM
Tygh Capital Management Portland, Oregon $782M AUM 39.44% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return

Dorsey Wright & Associates's PLSE Position: Q1 2021 in Review

Dorsey Wright & Associates sold out of Pulse Biosciences (PLSE) in Q1 2021, closing a stake of 767 shares — an estimated $18K sold.

Dorsey Wright & Associates first reported a position in PLSE in Q4 2020 and held it in 1 quarter. The position peaked at $18K in Q4 2020. 58 funds tracked by Wall St. Rank hold PLSE as of Q1 2021.

  • Dorsey Wright & Associates reported no remaining Pulse Biosciences position as of Q1 2021 after selling out during the quarter.
  • Dorsey Wright & Associates sold 767 Pulse Biosciences shares in Q1 2021, an estimated $18K.
  • Dorsey Wright & Associates first reported a position in Pulse Biosciences in Q4 2020 and held it in 1 quarter.
  • Dorsey Wright & Associates's Pulse Biosciences position peaked at $18K in Q4 2020.
  • 58 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2021.

Based on Dorsey Wright & Associates's 13F filing for Q1 2021, filed 27 Apr 2021.